Olive Medicine
Latest round
- Angel
Last raised
- Aug 2020
Total raised
- $2.2M
Investors
- 1
About Olive Medicine
Established in 2019 and based in Shenzhen, China, Olive Medicine operates as a medical company that focuses on the research and development of small-molecule drug therapy. Olive Medicine's main business is the research and development of small-molecule drug therapy. Its developed small-molecule drugs are based on traditional Chinese Medicine (TCM) and natural plants, with preventive and curative potentials. Products can be used in the treatment of diseases such as aging and related metabolic disorders.
Who invested in Olive Medicine
1 investor across 1 round
See all investors in Olive Medicine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Aug 17, 2020
Amount
$2.2M
Investors
Questions about Olive Medicine
Who invested in Olive Medicine?
Olive Medicine has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Olive Medicine raised?
Olive Medicine has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Olive Medicine last raise money?
Olive Medicine's most recent round on record is a Angel, in Aug 2020.
What does Olive Medicine do?
Established in 2019 and based in Shenzhen, China, Olive Medicine operates as a medical company that focuses on the research and development of small-molecule drug therapy.
Where is Olive Medicine headquartered?
Olive Medicine is headquartered in Shenzhen, China.
Which VCs invest in companies like Olive Medicine?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Olive Medicine's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Olive Medicine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.